New hope for myeloma patients with kidney trouble: denosumab shows promise

NCT ID NCT02833610

First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 31 times

Summary

This study tested the drug denosumab in 55 people with multiple myeloma who also have kidney problems. The goal was to see if it could help manage bone damage caused by the cancer. Researchers measured changes in bone markers and watched for side effects like low calcium levels.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Dana-Farber Cancer Institute

    Boston, Massachusetts, 02215, United States

  • Emory University Hospital

    Atlanta, Georgia, 30322, United States

  • Mass General/North Shore Cancer Center

    Danvers, Massachusetts, 01923, United States

  • Massachusetts general Hospital

    Boston, Massachusetts, 02114, United States

  • Newton Wellesley Hospital

    Newton, Massachusetts, 02462, United States

  • University Hospitals of Cleveland

    Cleveland, Ohio, 44106, United States

  • University of Rochester Medical Center

    Rochester, New York, 14642, United States

Conditions

Explore the condition pages connected to this study.